These pathways are frequently dysregulated via overexpression of EGFR in many cancers, including brain tumors, head and neck cancers, lung cancers, breast cancers, pancreatic cancers, kidney cancers, prostate cancers, ovary cancers, bladder cancers, and colorectal cancers.(4). Here, EGFR is linked to colorectal cancer.